Substance / Medication

Doxycycline monohydrate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

22 trials linked to this intervention

22
Total Trials
1
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Sylvatic plague management and prairie dogs - a meta-analysis.
Roth Jeffrey D · J Vector Ecol · 2019
PMID: 31124237Meta-Analysis
Vaccines for preventing plague.
Jefferson T, Demicheli V, Pratt M · Cochrane Database Syst Rev · 2000
PMID: 10796565Meta-AnalysisFull text (PMC)
Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.
Mwengee William, Butler Thomas, Mgema Samuel et al. · Clin Infect Dis · 2006
PMID: 16447105RCT
Morbihan disease: successful treatment with slow-releasing doxycycline monohydrate.
Chaidemenos G, Apalla Z, Sidiropoulos T · J Eur Acad Dermatol Venereol · 2018
PMID: 28833773Case Report
Treatment of rosacea with doxycycline monohydrate.
Bikowski J B · Cutis · 2000
PMID: 10955198Case Report
Subantimicrobial-dose doxycycline monohydrate in dermatology.
Wollina Uwe · Wien Med Wochenschr · 2015
PMID: 26564206Other
Electrospun nanofibers comprising of silk fibroin/gelatin for drug delivery applications: Thyme essential oil and doxycycline monohydrate release study.
Dadras Chomachayi Masoud, Solouk Atefeh, Akbari Somaye et al. · J Biomed Mater Res A · 2018
PMID: 29210169Preclinical
Tolerability of doxycycline monohydrate salt vs. chloroquine-proguanil in malaria chemoprophylaxis.
Pagès Frédéric, Boutin Jean-Paul, Meynard Jean-Baptiste et al. · Trop Med Int Health · 2002
PMID: 12390596Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Doxycycline monohydrate (substance)
SNOMED CT
81508005
UMLS CUI
C0700451

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

12
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
22
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.